Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.79 USD | +0.47% | -3.60% | +4.70% |
May. 22 | Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target | MT |
May. 16 | Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing | MT |
Chart calendar Bio-Techne Corporation
Upcoming events on Bio-Techne Corporation
Past events on Bio-Techne Corporation
2024-05-20 | Benchmark Healthcare House Virtual Conference |
2024-05-14 05:20 pm | BofA Securities Health Care Conference |
2024-05-10 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract 1463 |
2024-05-09 | Ex-dividend day |
2024-05-09 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract 1329 |
2024-05-09 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract 1398 |
2024-05-09 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract 1397 |
2024-05-09 08:30 am | American Society of Gene & Cell Therapy Meeting |
2024-05-08 04:45 pm | American Society of Gene & Cell Therapy Meeting |
2024-05-08 03:45 pm | American Society of Gene & Cell Therapy Meeting |
2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract 868 |
2024-05-01 09:00 am | Q3 2024 Earnings Call |
2024-05-01 06:30 am | Q3 2024 Earnings Release |
2024-04-10 12:00 pm | American Association for Cancer Research Meeting - Abstract No: LB393 |
2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No: 4626 |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No: 3797 |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract No: 3773 |
2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Abstract No: 943 |
2024-03-19 09:45 am | KeyBanc Life Sciences & MedTech Forum |
2024-03-13 08:30 am | Barclays Global Healthcare Conference |
Past dividends on Bio-Techne Corporation
2024-05-09 | Quarterly 0.08 USD |
2024-02-08 | Quarterly 0.08 USD |
2023-11-08 | Quarterly 0.08 USD |
2023-08-16 | Quarterly 0.08 USD |
2023-05-11 | Quarterly 0.08 USD |
2023-02-09 | Quarterly 0.08 USD |
2022-11-09 | Quarterly 0.32 USD |
2022-08-11 | Quarterly 0.32 USD |
2022-05-12 | Quarterly 0.32 USD |
2022-02-09 | Quarterly 0.32 USD |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 714 722 -1.1% | 739 728 1.46% | 931 916 1.59% | 1 106 1 108 -0.24% | 1 137 1 143 -0.51% | 1 159 |
EBITDA Million USD | Released Forecast Spread | 264 280 -5.54% | 268 254 5.36% | 386 378 1.97% | 449 449 0.14% | 441 446 -1.04% | 409 |
EBIT Million USD | Released Forecast Spread | 245 248 -1.47% | 246 233 5.66% | 362 354 2.29% | 421 424 -0.67% | 410 412 -0.53% | 372 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 112 130 -13.57% | 276 230 19.97% | 148 200 -25.75% | 301 294 2.64% | 339 331 2.36% | 207 |
Net income Million USD | Released Forecast Spread | 96,1 110 -12.32% | 229 181 26.37% | 140 169 -17.15% | 272 270 0.74% | 285 274 4.06% | 180 |
EPS USD | Released Forecast Spread | 0,62 0,71 -12.41% | 1,46 1,15 26.58% | 0,87 1,05 -17.26% | 1,66 1,64 1.22% | 1,76 1,69 4.05% | 1,12 |
Announcement Date | 06/08/19 | 04/08/20 | 05/08/21 | 04/08/22 | 08/08/23 | - |
Quarterly results
Fiscal Period | Juni | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 290 279 3.98% | 288 287 0.41% | 270 282 -4.29% | 272 290 -6.26% | 294 299 -1.48% | 301 308 -2.26% | 277 288 -3.72% | 273 278 -1.85% | 303 293 3.65% | 306 | 290 | 297 | 326 | 333 |
EBITDA Million USD | Released Forecast Spread | 122 116 4.59% | 114 113 1.34% | 101 102 -1.04% | 104 109 -4.49% | 116 117 -0.9% | 120 122 -1.32% | 95,6 99,1 -3.51% | 93,2 98,1 -4.92% | 109 103 5.74% | 112 | 102 | 106 | 124 | 128 |
EBIT Million USD | Released Forecast Spread | 115 107 6.79% | 107 111 -3.64% | 93,2 97,5 -4.47% | 96,5 103 -5.98% | 109 110 -1.33% | 112 114 -1.51% | 86,9 91,9 -5.41% | 81,9 87,2 -6.03% | 99,6 94,4 5.52% | 103 | 93,3 | 96,4 | 113 | 117 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 68,8 72,5 -5.1% | 79,1 77,2 2.4% | 104 64,4 61.11% | 66,4 73,9 -10.12% | 80,2 77,2 3.92% | 88,3 80,5 9.71% | 49,6 61,1 -18.87% | 33,4 53,7 -37.86% | 61,1 56,0 9.09% | 63,6 | 55,0 | 60,2 | 78,8 | 81,6 |
Net income Million USD | Released Forecast Spread | 60,7 57,6 5.4% | 61,5 62,6 -1.79% | 89,6 52,8 69.62% | 50,0 55,4 -9.73% | 70,2 63,1 11.3% | 75,5 64,0 17.92% | 51,0 47,1 8.25% | 27,5 43,3 -36.5% | 49,1 46,7 5.06% | 52,8 | 41,7 | 47,0 | 61,7 | 64,6 |
EPS USD | Released Forecast Spread | 0,37 0,35 5.97% | 0,38 0,38 -0.66% | 0,55 0,32 70.22% | 0,31 0,34 -9.05% | 0,43 0,39 10.26% | 0,47 0,40 18.49% | 0,31 0,29 6.28% | 0,17 0,27 -35.85% | 0,31 0,29 7.64% | 0,33 | 0,27 | 0,30 | 0,39 | 0,41 |
Announcement Date | 04/05/22 | 04/08/22 | 01/11/22 | 02/02/23 | 03/05/23 | 08/08/23 | 31/10/23 | 01/02/24 | 01/05/24 | - | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Bio-Techne Corporation
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TECH Stock
- Calendar Bio-Techne Corporation